Found 178 results
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
M. W. Mutuku, Laidemitt, M. R., Beechler, B. R., Mwangi, I. N., Otiato, F. O., Agola, E. L., Ochanda, H., Kamel, B., Mkoji, G. M., Steinauer, M. L., and Loker, E. S., A Search for Snail-Related Answers to Explain Differences in Response of to Praziquantel Treatment among Responding and Persistent Hotspot Villages along the Kenyan Shore of Lake Victoria., Am J Trop Med Hyg, vol. 101, no. 1, pp. 65-77, 2019.
M. L. Musser, Curran, K. M., Flesner, B. K., and Johannes, C. M., A Retrospective Evaluation of Chemotherapy Overdoses in Dogs and Cats., Front Vet Sci, vol. 8, p. 718967, 2021.
C. A. Murray, Willcox, J. L., Souza, C. H. De Mello, Husbands, B., Cook, M. R., Clifford, C., Leeper, H., Pellin, M. Kenzie, Richardson, D., Herrera, C. L., Krick, E., McMillan, S., Al-Nadaf, S., and Skorupski, K. A., Outcome in dogs with curative-intent treatment of localized primary pulmonary histiocytic sarcoma., Vet Comp Oncol, 2021.
K. N. Murray, Varga, Z. M., and Kent, M. L., Biosecurity and Health Monitoring at the Zebrafish International Resource Center., Zebrafish, vol. 13 Suppl 1, pp. S30-8, 2016.
K. N. Murray, Wolf, J. C., Spagnoli, S. T., Lains, D., Budrow, N., and Kent, M. L., Reversibility of Proliferative Thyroid Lesions Induced by Iodine Deficiency in a Laboratory Zebrafish Colony., Zebrafish, vol. 15, no. 6, pp. 558-565, 2018.
M. K. Muramatsu, Brothwell, J. A., Stein, B. D., Putman, T. E., Rockey, D. D., and Nelson, D. E., Beyond Tryptophan Synthase: Identification of Genes That Contribute to Chlamydia trachomatis Survival during Gamma Interferon-Induced Persistence and Reactivation., Infect Immun, vol. 84, no. 10, pp. 2791-801, 2016.
D. M. Mulrooney, Johnson, M. R., Smith, B. B., and Zimmerman, G. L., Clinical reference values for serum protein electrophoresis for the llama (Lama glama)., American journal of veterinary research, vol. 50, no. 11, pp. 1889-92, 1989.
S. Mukherjee, Petrofsky, M., Yaraei, K., Bermudez, L. E., and Cangelosi, G. A., The white morphotype of Mycobacterium avium-intracellulare is common in infected humans and virulent in infection models., The Journal of infectious diseases, vol. 184, no. 11, pp. 1480-4, 2001.
M. C. Mudge, Walker, N. J., Borjesson, D. L., Librach, F., Johns, J. L., and Owens, S. D., Post-transfusion survival of biotin-labeled allogeneic RBCs in adult horses., Vet Clin Pathol, vol. 41, no. 1, pp. 56-62, 2012.
P. W. Mshelia, Kappmeyer, L., Johnson, W. C., Kudi, C. A., Oluyinka, O. O., Balogun, E. O., Richard, E. E., Onoja, E., Sears, K. P., and Ueti, M. W., Molecular detection of Theileria species and Babesia caballi from horses in Nigeria., Parasitol Res, vol. 119, no. 9, pp. 2955-2963, 2020.
D. MS, KW, H., KK, W., McKenzie, E. C., and CM, R., Effect of multiday exercise on serum hormone and substrate concentrations in racing sled dogs, Comparative Exercise Physiology , pp. 197-205, 2020.
H. M. Moulton, In vivo delivery of morpholino oligos by cell-penetrating peptides., Curr Pharm Des, vol. 19, no. 16, pp. 2963-9, 2013.
H. M. Moulton, Wu, B., Jearawiriyapaisarn, N., Sazani, P., Lu, Q. Long, and Kole, R., Peptide-morpholino conjugate: a promising therapeutic for Duchenne muscular dystrophy., Annals of the New York Academy of Sciences, vol. 1175, pp. 55-60, 2009.
H. M. Moulton, Yoshihara, P. H., Mason, D. H., Iversen, P. L., and Triozzi, P. L., Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival., Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 8, no. 7, pp. 2044-51, 2002.
H. M. Moulton and Moulton, J. D., Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy., Biochimica et biophysica acta, vol. 1798, no. 12, pp. 2296-303, 2010.
H. M. Moulton and Moulton, J. D., Peptide-assisted delivery of steric-blocking antisense oligomers., Current opinion in molecular therapeutics, vol. 5, no. 2, pp. 123-32, 2003.
H. M. Moulton, Cell-penetrating peptides enhance systemic delivery of antisense morpholino oligomers., Methods in molecular biology (Clifton, N.J.), vol. 867, pp. 407-14, 2012.
H. M. Moulton, Hase, M. C., Smith, K. M., and Iversen, P. L., HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers., Antisense & nucleic acid drug development, vol. 13, no. 1, pp. 31-43, 2003.
H. M. Moulton and JD, M., Morpholino Oligomers: Methods and Protocols. Methods in Molecular Biology. Humana Press, 2017.
H. M. Moulton, Fletcher, S., Neuman, B. W., McClorey, G., Stein, D. A., Abes, S., Wilton, S. D., Buchmeier, M. J., Lebleu, B., and Iversen, P. L., Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo., Biochemical Society transactions, vol. 35, no. Pt 4, pp. 826-8, 2007.
H. M. Moulton, In vivo delivery of morpholino oligos by cell-penetrating peptides., Current pharmaceutical design, vol. 19, no. 16, pp. 2963-9, 2013.
H. M. Moulton, Nelson, M. H., Hatlevig, S. A., Reddy, M. T., and Iversen, P. L., Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides., Bioconjugate chemistry, vol. 15, no. 2, pp. 290-9, 2004.
H. M. Moulton and Moulton, J. D., Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy., Biochim Biophys Acta, vol. 1798, no. 12, pp. 2296-303, 2010.
H. M. Moulton and Moulton, J. D., Arginine-rich cell-penetrating peptides with uncharged antisense oligomers., Drug discovery today, vol. 9, no. 20, p. 870, 2004.
N. Motamedi, Danelishvili, L., and Bermudez, L. E., Identification of Mycobacterium avium genes associated with resistance to host antimicrobial peptides., Journal of medical microbiology, vol. 63, no. Pt 7, pp. 923-30, 2014.

Pages